Right Ventricular Septal Biopsy to Detect Cardiac Amyloidosis

Study acronym: RV-CAM
StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Geisinger Clinic
32 trials monitored
See 3 trials at risk
Heart Disease
8,814 trials monitored
See 428 trials at risk
Heart Failure
2,000 trials monitored
See 115 trials at risk
Amyloidosis
330 trials monitored
See 20 trials at risk
People eligible for this study have had the suggestion from their doctor to receive a cardiac pacemaker or defibrillator to treat a cardiac condition as part of their routine care. We are doing this study to understand if obtaining a tissue sample from their body during a device implant may assist in the early diagnosis of Transthyretin Cardiac Amyloidosis (ATTR-CM).
Trial Details
NCT Number NCT07784712
Lead Sponsor Geisinger Clinic
Conditions
(from sponsor)		 ATTR-CM (Transthyretin Amyloid Cardiomyopathy), Heart Failure
Related terms Amyloid Neuropathies, Familial, Heart Failure
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov